3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
8
Osteoporosis
8
Vitamin D Deficiency
4
Polycystic Ovary Syndrome
4
Colonic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Colorectal Neoplasms
3
Bone Diseases, Metabolic
3
Obesity
2
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Inflammation
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Solid Cancers
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Interventions
Surveys and Questionnaires
5
Pemetrexed
3
Paclitaxel
3
Gemcitabine
3
Docetaxel
3
Brachytherapy
3
pembrolizumab
2
Topotecan
2
Saline Solution
2
Radiotherapy
2
Radiation
2
FANG vaccine
2
Everolimus
2
Doxorubicin
2
Cisplatin
2
Carboplatin
2
CP protocol
2
temsirolimus
1
selinexor
1
osimertinib
1
niraparib
1
fosaprepitant
1
ferumoxtran-10
1
ferrous fumarate
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alovudine
1
Vitamin D
1
Uterine Artery Embolization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Neoplasms
×
Vitamin D
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled